Last reviewed · How we verify
NCT03238391
Ischemic Preconditioning for Prevention of Contrast Nephropathy in The Emergency Department
NA trial testing Ischemic preconditioning in Contrast-induced Nephropathy in 350 participants. Status unknown.
15 February 2018
Quick facts
| Lead sponsor | Derince Training and Research Hospital |
|---|---|
| Phase | NA |
| Status | Status unknown |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | double |
| Primary purpose | prevention |
| Enrollment | 350 |
| Start date | 15 August 2017 |
| Primary completion | 15 February 2018 |
| Estimated completion | 15 February 2018 |
Drugs / interventions tested
- Ischemic preconditioning — full drug profile →
Conditions studied
- Contrast-induced Nephropathy — all drugs for Contrast-induced Nephropathy →
Sponsor
Derince Training and Research Hospital
Who can join
18 and older, any sex, with Contrast-induced Nephropathy. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The purpose of this study is to demonstrate the effectiveness of ischemic preconditioning in the emergency department to prevent contrast induced nephropathy
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT03238391
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Ischemic preconditioning
Trials testing the same drug.
- NCT06825143 — Therapeutic Strategies to Reduce Endothelial Ischemia-reperfusion Injury · EARLY_PHASE1 · not yet recruiting
- NCT07497958 — Ischemic Preconditioning Reduces the Severity of Acute Kidney Injury After Partial Nephrectomy · NA · not yet recruiting
- NCT06236633 — Safety & Efficacy of Ischemic Preconditioning by Embolization of the Inferior Mesenteric Artery in Surgery for Tumors of · NA · recruiting
- NCT04887610 — Factors That Influence Blood Vessel Regulation During Exercise in Humans · NA · completed
- NCT03136458 — Efficacy of Remote Ischemic Preconditioning as Non Pharmacologic Strategy to Prevent Contrast Induced Nephropathy (PAIR) · NA · withdrawn
Other recruiting trials for Contrast-induced Nephropathy
Currently open trials in the same condition.
- NCT07459413 — Oral vs. Intravenous Hydration to Prevent Contrast-Associated Acute Kidney Injury in the ED · NA · recruiting
- NCT06418542 — Contrast Nephropathy Associated FFA · Phase 4 · active not recruiting
- NCT04606056 — Risk of Acute Kidney Injury After Intravenous Contrast Computed Tomography Scans · active not recruiting
- NCT05283512 — Intravenous vs. Oral Hydration to Reduce the Risk of Post-Contrast Acute Kidney Injury After Intravenous Contrast-Enhanc · NA · recruiting
Other Derince Training and Research Hospital trials
Trials by the same sponsor.
- NCT06107543 — Lidocaine in the Prevention of Hemodynamic Response to Laryngoscopy and Endotracheal Intubation · completed
- NCT06274372 — The Effect of Flow-controlled Ventilation on Hemodynamic and Respiratory Parameters in Laparoscopic Surgeries · NA · completed
- NCT05684900 — Research of the Effect of Reservoir Oxygen Mask Application on Respiratory Parameters in Sedated Adult Patients for Gast · completed
- NCT05091606 — Lower and Upper Extremity Perfusion Index (PI) in Pregnant Women Under Spinal Anesthesia · unknown
- NCT04920851 — Cytokine Hemadsorption in Covid 19 Patients With Bacterial Sepsis · unknown
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03238391 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Derince Training and Research Hospital
- Last refreshed: 3 August 2017
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03238391.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing